Publications by authors named "Isabelle Trouilloud"

Claim this Profile
T
TRYBECA-1: A Randomized Phase III Study of Eryaspase Combined With Chemotherapy Versus Chemotherapy as Second-Line Treatment in Patients With Advanced Pancreatic Adenocarcinoma.
Pascal Hammel, Jean-Philippe Metges, Teresa Macarulla Mercade, Rocio Garcia-Carbonero, Olivier Bouché, Isabelle Trouilloud

J Clin Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Switch from cetuximab to panitumumab during encorafenib-based therapy in BRAF V600E mutated metastatic colorectal cancer: an international multicenter analysis from the AGEO group.
Annalice Gandini, Victoria Probst, Matteo Landi, Maria Caterina De Grandis, Chiara Cremolini, Isabelle Trouilloud

Clin Res Hepatol Gastroenterol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma Protein Biomarkers to Detect Early Gastric Preneoplasia and Cancer: A Prospective Study.
Quentin Giai Gianetto, Valérie Michel, Thibaut Douché, Karine Nozeret, Aziz Zaanan, Isabelle Trouilloud

Int J Mol Sci· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive and prognostic factors of efficacy of third-line chemotherapy in patients with unresectable pancreatic cancer: a cohort-based study.
Camille Evrard, Antoine Pelras, Simon Rivet, Jean-Baptiste Bachet, Olivier Dubreuil, Isabelle Trouilloud

Oncologist· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Olaparib as maintenance therapy in non resectable pancreatic adenocarcinoma associated with homologous recombination deficiency profile: A French retrospective multicentric AGEO real-world study.
Jeannie M'Baloula, David Tougeron, Alice Boilève, Elodie Jeanbert, Rosine Guimbaud, Isabelle Trouilloud

Eur J Cancer· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Digital tool to identify and monitor regorafenib-associated hand-foot skin reactions: A proof-of-concept study protocol.
Romain Coriat, Vincent Sibaud, Vincent Bourgeois, Sylvain Manfredi, Pascal Artru, Isabelle Trouilloud

Dig Liver Dis· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemotherapy in advanced pancreatic adenosquamous carcinoma: A retrospective multicenter AGEO study.
Marie Auvray Kuentz, Vincent Hautefeuille, Louis de Mestier, Clélia Coutzac, Thierry Lecomte, Isabelle Trouilloud

Int J Cancer· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Performance of a blood-based RNA signature for gemcitabine-based treatment in metastatic pancreatic adenocarcinoma.
David Piquemal, Roman Bruno, Barbara Bournet, Francois Ghiringhelli, Florian Noguier, Isabelle Trouilloud

J Gastrointest Oncol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sequential Treatment With Trifluridine/Tipiracil and Regorafenib in Refractory Metastatic Colorectal Cancer Patients: An AGEO Prospective "Real-World Study".
Clélia Coutzac, Isabelle Trouilloud, Pascal Artru, Julie Henriques, Thérese Masson

Clin Colorectal Cancer· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Local treatment of pancreatic cancer metastases: A multicenter French study of the AGEO group.
Clémence Breton, Antoine Meyer, David Malka, Margarida Matias, Thierry De Baere, Isabelle Trouilloud

Clin Res Hepatol Gastroenterol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monitoring levels of circulating cell-free DNA in patients with metastatic colorectal cancer as a potential biomarker of responses to regorafenib treatment.
Brice Pastor, Thierry André, Julie Henriques, Isabelle Trouilloud, Christophe Tournigand

Mol Oncol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic value of the early change in neutrophil-to-lymphocyte ratio in metastatic pancreatic adenocarcinoma.
Paul McLellan, Julie Henriques, Feryel Ksontini, Solène Doat, Pascal Hammel, Isabelle Trouilloud

Clin Res Hepatol Gastroenterol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reasons for chemotherapy discontinuation and end-of-life in patients with gastrointestinal cancer: A multicenter prospective AGEO study.
Lola-Jade Palmieri, Olivier Dubreuil, Jean-Baptiste Bachet, Isabelle Trouilloud, Christophe Locher

Clin Res Hepatol Gastroenterol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Three fluoropyrimidine-based regimens in routine clinical practice after nab-paclitaxel plus gemcitabine for metastatic pancreatic cancer: An AGEO multicenter study.
Anne-Laure Pointet, David Tougeron, Simon Pernot, Astrid Pozet, Dominique Béchade, Isabelle Trouilloud

Clin Res Hepatol Gastroenterol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Withholding the Introduction of Anti-Epidermal Growth Factor Receptor: Impact on Outcomes in RAS Wild-Type Metastatic Colorectal Tumors: A Multicenter AGEO Study (the WAIT or ACT Study).
Lola-Jade Palmieri, Laurent Mineur, David Tougeron, Benoît Rousseau, Victoire Granger, Isabelle Trouilloud

Oncologist· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristic and outcomes of patients with pathologic complete response after preoperative treatment in borderline and locally advanced pancreatic adenocarcinoma: An AGEO multicentric retrospective cohort.
Hampig Kourie, Edouard Auclin, Antonio Sa Cunha, Sebastien Gaujoux, Mathieu Bruzzi, Isabelle Trouilloud

Clin Res Hepatol Gastroenterol· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Folfirinox gemcitabine/nab-paclitaxel as first-line therapy in patients with metastatic pancreatic cancer: a comparative propensity score study.
Nicolas Williet, Angélique Saint, Anne-Laure Pointet, David Tougeron, Simon Pernot, Isabelle Trouilloud

Therap Adv Gastroenterol· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunotherapy and metastatic colorectal cancers with microsatellite instability or mismatch repair deficiency.
Romain Cohen, Anna Pellat, Hélène Boussion, Magali Svrcek, Daniel Lopez-Trabada, Isabelle Trouilloud

Bull Cancer· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[New molecular classification of colorectal cancer, pancreatic cancer and stomach cancer: Towards "à la carte" treatment?].
Chantal Dreyer, Pauline Afchain, Isabelle Trouilloud, Thierry André

Bull Cancer· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunotherapy and patients treated for cancer with microsatellite instability.
Raphaël Colle, Romain Cohen, Delphine Cochereau, Alex Duval, Olivier Lascols, Isabelle Trouilloud

Bull Cancer· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Adjuvant Chemotherapy in Colon Cancer With Microsatellite Instability: A Large Multicenter AGEO Study.
David Tougeron, Guillaume Mouillet, Isabelle Trouilloud, Thierry Lecomte, Romain Coriat

J Natl Cancer Inst· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sequential FOLFIRI.3 + Gemcitabine Improves Health-Related Quality of Life Deterioration-Free Survival of Patients with Metastatic Pancreatic Adenocarcinoma: A Randomized Phase II Trial.
Amélie Anota, Guillaume Mouillet, Isabelle Trouilloud, Anne-Claire Dupont-Gossart, Pascal Artru

PLoS One· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pathologic Major Response After FOLFIRINOX is Prognostic for Patients Secondary Resected for Borderline or Locally Advanced Pancreatic Adenocarcinoma: An AGEO-FRENCH, Prospective, Multicentric Cohort.
Daniel Pietrasz, Lysiane Marthey, Mathilde Wagner, Jean-Frédéric Blanc, Christophe Laurent, Isabelle Trouilloud

Ann Surg Oncol· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Second-line chemotherapy for advanced biliary tract cancer after failure of the gemcitabine-platinum combination: A large multicenter study by the Association des Gastro-Entérologues Oncologues.
Bertrand Brieau, Laetitia Dahan, Yann De Rycke, Tarek Boussaha, Philippe Vasseur, Isabelle Trouilloud

Cancer· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fixed-dose rate gemcitabine alone or alternating with FOLFIRI.3 (irinotecan, leucovorin and fluorouracil) in the first-line treatment of patients with metastatic pancreatic adenocarcinoma: an AGEO randomised phase II study (FIRGEM).
Isabelle Trouilloud, Anne-Claire Dupont-Gossard, David Malka, Pascal Artru, Mélanie Gauthier

Eur J Cancer· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis